These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 29281266)
21. MTH1 deficiency selectively increases non-cytotoxic oxidative DNA damage in lung cancer cells: more bad news than good? Abbas HHK; Alhamoudi KMH; Evans MD; Jones GDD; Foster SS BMC Cancer; 2018 Apr; 18(1):423. PubMed ID: 29661172 [TBL] [Abstract][Full Text] [Related]
22. Programmed cell death triggered by nucleotide pool damage and its prevention by MutT homolog-1 (MTH1) with oxidized purine nucleoside triphosphatase. Nakabeppu Y; Oka S; Sheng Z; Tsuchimoto D; Sakumi K Mutat Res; 2010 Nov; 703(1):51-8. PubMed ID: 20542142 [TBL] [Abstract][Full Text] [Related]
23. Mouse MTH2 protein which prevents mutations caused by 8-oxoguanine nucleotides. Cai JP; Ishibashi T; Takagi Y; Hayakawa H; Sekiguchi M Biochem Biophys Res Commun; 2003 Jun; 305(4):1073-7. PubMed ID: 12767940 [TBL] [Abstract][Full Text] [Related]
24. MTH1 as a nucleotide pool sanitizing enzyme: Friend or foe? Nakabeppu Y; Ohta E; Abolhassani N Free Radic Biol Med; 2017 Jun; 107():151-158. PubMed ID: 27833032 [TBL] [Abstract][Full Text] [Related]
25. Visualization of oxidized guanine nucleotides accumulation in living cells with split MutT. Fujikawa Y; Kawai H; Suzuki T; Kamiya H Nucleic Acids Res; 2024 Jun; 52(11):6532-6542. PubMed ID: 38738661 [TBL] [Abstract][Full Text] [Related]
26. Understanding the molecular mechanism for the differential inhibitory activities of compounds against MTH1. Wang M; Zhou S; Chen Q; Wang L; Liang Z; Wang J Sci Rep; 2017 Jan; 7():40557. PubMed ID: 28074893 [TBL] [Abstract][Full Text] [Related]
27. Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy. Huber KV; Salah E; Radic B; Gridling M; Elkins JM; Stukalov A; Jemth AS; Göktürk C; Sanjiv K; Strömberg K; Pham T; Berglund UW; Colinge J; Bennett KL; Loizou JI; Helleday T; Knapp S; Superti-Furga G Nature; 2014 Apr; 508(7495):222-7. PubMed ID: 24695225 [TBL] [Abstract][Full Text] [Related]
28. An oxidized purine nucleoside triphosphatase, MTH1, suppresses cell death caused by oxidative stress. Yoshimura D; Sakumi K; Ohno M; Sakai Y; Furuichi M; Iwai S; Nakabeppu Y J Biol Chem; 2003 Sep; 278(39):37965-73. PubMed ID: 12857738 [TBL] [Abstract][Full Text] [Related]
29. Differential anti-tumour effects of MTH1 inhibitors in patient-derived 3D colorectal cancer cultures. van der Waals LM; Laoukili J; Jongen JMJ; Raats DA; Borel Rinkes IHM; Kranenburg O Sci Rep; 2019 Jan; 9(1):819. PubMed ID: 30692572 [TBL] [Abstract][Full Text] [Related]
30. Proteomic profiling of small-molecule inhibitors reveals dispensability of MTH1 for cancer cell survival. Kawamura T; Kawatani M; Muroi M; Kondoh Y; Futamura Y; Aono H; Tanaka M; Honda K; Osada H Sci Rep; 2016 May; 6():26521. PubMed ID: 27210421 [TBL] [Abstract][Full Text] [Related]
31. The MTH1 inhibitor TH588 demonstrates anti-tumoral effects alone and in combination with everolimus, 5-FU and gamma-irradiation in neuroendocrine tumor cells. Aristizabal Prada ET; Orth M; Nölting S; Spöttl G; Maurer J; Auernhammer C PLoS One; 2017; 12(5):e0178375. PubMed ID: 28542590 [TBL] [Abstract][Full Text] [Related]
32. Cellular 8-oxo-7,8-dihydro-2'-deoxyguanosine 5'-triphosphate pyrophosphohydrolase activity of human and mouse MTH1 proteins does not depend on the proliferation rate. Bialkowski K; Kasprzak KS Free Radic Biol Med; 2004 Nov; 37(10):1534-41. PubMed ID: 15477005 [TBL] [Abstract][Full Text] [Related]
33. TH1579, MTH1 inhibitor, delays tumour growth and inhibits metastases development in osteosarcoma model. Moukengue B; Brown HK; Charrier C; Battaglia S; Baud'huin M; Quillard T; Pham TM; Pateras IS; Gorgoulis VG; Helleday T; Heymann D; Berglund UW; Ory B; Lamoureux F EBioMedicine; 2020 Mar; 53():102704. PubMed ID: 32151797 [TBL] [Abstract][Full Text] [Related]
35. Identification and structure-activity relationship of purine derivatives as novel MTH1 inhibitors. Kumar A; Kawamura T; Kawatani M; Osada H; Zhang KYJ Chem Biol Drug Des; 2017 Jun; 89(6):862-869. PubMed ID: 27863017 [TBL] [Abstract][Full Text] [Related]
36. Solution structure and NH exchange studies of the MutT pyrophosphohydrolase complexed with Mg(2+) and 8-oxo-dGMP, a tightly bound product. Massiah MA; Saraswat V; Azurmendi HF; Mildvan AS Biochemistry; 2003 Sep; 42(34):10140-54. PubMed ID: 12939141 [TBL] [Abstract][Full Text] [Related]
37. Mutational specificity of mice defective in the MTH1 and/or the MSH2 genes. Egashira A; Yamauchi K; Yoshiyama K; Kawate H; Katsuki M; Sekiguchi M; Sugimachi K; Maki H; Tsuzuki T DNA Repair (Amst); 2002 Nov; 1(11):881-93. PubMed ID: 12531017 [TBL] [Abstract][Full Text] [Related]
38. Reactive Oxygen Species Dictate the Apoptotic Response of Melanoma Cells to TH588. Wang JY; Jin L; Yan XG; Sherwin S; Farrelly M; Zhang YY; Liu F; Wang CY; Guo ST; Yari H; La T; McFarlane J; Lei FX; Tabatabaee H; Chen JZ; Croft A; Jiang CC; Zhang XD J Invest Dermatol; 2016 Nov; 136(11):2277-2286. PubMed ID: 27427486 [TBL] [Abstract][Full Text] [Related]
39. Novel Class of Potent and Cellularly Active Inhibitors Devalidates MTH1 as Broad-Spectrum Cancer Target. Ellermann M; Eheim A; Rahm F; Viklund J; Guenther J; Andersson M; Ericsson U; Forsblom R; Ginman T; Lindström J; Silvander C; Trésaugues L; Giese A; Bunse S; Neuhaus R; Weiske J; Quanz M; Glasauer A; Nowak-Reppel K; Bader B; Irlbacher H; Meyer H; Queisser N; Bauser M; Haegebarth A; Gorjánácz M ACS Chem Biol; 2017 Aug; 12(8):1986-1992. PubMed ID: 28679043 [TBL] [Abstract][Full Text] [Related]
40. Molecular genetics and structural biology of human MutT homolog, MTH1. Nakabeppu Y Mutat Res; 2001 Jun; 477(1-2):59-70. PubMed ID: 11376687 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]